Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Clinical Therapeutics|February 2, 2021
Nonalcoholic Fatty Liver Disease: A Global PerspectiveWei-Kei Wong, Wah-Kheong ChanNephrology (Carlton, Vic.)|June 3, 2023
Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?Wei-Kei Wong, Wah-Kheong Chan, Shubash Ganapathy, et al.Seminars in Dialysis|July 12, 2022
Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in MalaysiaWei-Kei Wong, Wah-Kheong Chan, Shubash Shander Ganapathy, et al.Case Reports in Nephrology and Dialysis|August 11, 2022
Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung InvolvementAlbert Hing Wong, Wei-Kei Wong, Lai-Meng Looi, et al.Clinical Transplantation|March 31, 2026
Cardiovascular and Renal Outcomes Among Kidney Transplant Recipients With Metabolic Syndrome: A Systematic Review and Meta-AnalysisMin Yie Lim, Loke Yuan Shee, Zhi Yong Wong, et al.Pageof 1